n-(1-methyl-2-phenylethyl)adenosine has been researched along with thioridazine in 1 studies
Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (thioridazine) | Trials (thioridazine) | Recent Studies (post-2010) (thioridazine) |
---|---|---|---|---|---|
134 | 0 | 4 | 2,501 | 255 | 207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bridges, AJ; Bristol, JA; Bruns, RF; Downs, DA; Heffner, TG; Moos, WH; Szotek, DL; Trivedi, BK | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and thioridazine
Article | Year |
---|---|
N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.
Topics: Adenosine; Animals; Antipsychotic Agents; Ataxia; Avoidance Learning; Dose-Response Relationship, Drug; Haloperidol; Motor Activity; Rats; Receptors, Purinergic; Structure-Activity Relationship; Thioridazine | 1987 |